Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 6 35-6, 1997, Pages

  Divertie, G D ^b   Jensen, M D ^b   Cryer, P E ^b   Miles, J M ^a  

^a ST LUKE S HOSPITAL   (United States)

^b NONE

Author keywords

Free fatty acids; Insulin dependent diabetes mellitus; Kinetics; Lipolysis

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADRENALIN; FATTY ACID; PALMITIC ACID;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOLYSIS; MALE; PRIORITY JOURNAL;

EID: 0030871283     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.6.e1130     Document Type: Article

References (35)

1. Arner, P., E. Kriegholm, and P. Engfeldt. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. J. Pharmacol. Exp. Ther. 259: 317-322, 1991.
2. Arner, P., E. Kriegholm, P. Engfeldt, and J. Bolinder. Adrenergic regulation of lipolysis in situ at rest and during exercise. J. Clin. Invest. 85: 893-898, 1990.
3. Arner, P., and J. Ostman. Abnormalities in the adrenergic control and the rate of lipolysis in isolated human subcutaneous adipose tissue in diabetes mellitus. Diabetologia 12: 593-599, 1976.
4. Baker, L., R. Kaye, and N. Haque. Metabolic homeostasis in juvenile diabetes mellitus. Diabetes 18: 421-427, 1969.
5. Berk, M. A., W. E. Clutter, D. Skor, S. D. Shah, R. P. Gingerich, C. A. Parvin, and P. E. Cryer. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. J. Clin. Invest. 75: 1842-1851, 1985.
6. Beylot, M., B. Beaufrere, J. P. Riou, Y. Khalfallah, A. Moneger, M. Odeon, R. Cohen, and R. Mornex. Effect of epinephrine on the relationship between nonesterified fatty acid availability and ketone body production in postabsorptive man: evidence for a hepatic antiketogenic effect of epinephrine. J. Clin. Endocrinol Metab. 65: 914-921, 1987.
7. Cahill, G. F., M. G. Herrera, A. P. Morgan, J. S. Soeldner, J. Steike, P. L. Levy, G. A. Reichard, Jr., and D. M. Kipnis. Hormone fuel interrelationships during fasting. J. Clin. Invest. 45: 1751-1769, 1966.
8. Carlson, M. G., W. L. Snead, J. O. Hill, N. Nurjhan, and P. J. Campbell. Glucose regulation of lipid metabolism in humans. Am. J. Physiol 261 (Endocrinol. Metab. 24): E815-E820, 1991.
9. Caruso, M., G. D. Divertie, M. D. Jensen, and J. M. Miles. Lack of effect of hyperglycemia on lipolysis in humans. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E542-E547, 1990.
10. Christensen, N. J. Plasma norepinephrine and epinephrine in untreated diabetes, during fasting and after insulin administration. Diabetes 23: 1-8, 1974.
11. Christensen, N. J., H. Galbo, J. F. Hansen, B. Hesse, E. A. Richter, and J. Trap-Jensen. Catecholamines and exercise. Diabetes 28, Suppl. 1: 58-62, 1979.
12. Cryer, P. E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N. Engl. J. Med. 303: 436-444, 1980.
13. Faber, O., C. Binder, J. Markussen, L. Heding, V. Naithani, H. Kuzuya, P. Blix, D. Horwitz, and A. Rubenstein. Characterization of seven C-peptide antisera. Diabetes 27, Suppl. 1: 170-177, 1978.
14. Galster, A. D., W. E. Clutter, P. E. Cryer, J. A. Collins, and D. M. Bier. Epinephrine plasma thresholds for lipolytic effects in man. J. Clin. Invest. 67: 1729-1738, 1981.
15. Herbert, V., K. Lau, C. Gottlieb, and S. Bleicher. Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab. 25: 1375-1384, 1965.
16. Hill, A. V. The combination of haemoglobin with oxygen and with carbon monoxide. Biochem. J. 7: 471-480, 1913.
17. Hwang, D. L., G. Barseghian, and A. Lev-Ran. Determination of free insulin in antibody containing sera: comparison of polyethylene glycol and staphylococcus aureus cells. Horm. Metab. Res. 17: 595-597, 1985.
18. Jensen, M. D., M. Caruso, V. J. Heiling, and J. M. Miles. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38: 1595-1601, 1989.
19. Jensen, M. D., M. W. Haymond, J. E. Gerich, P. E. Cryer, and J. M. Miles. Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J. Clin. Invest. 79: 207-213, 1987.
20. Jensen, M. D., V. Heiling, and J. M. Miles. Measurement of non-steady-state free fatty acid turnover. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E103-E108, 1990.
21. Jensen, M. D., V. J. Heiling, and J. M. Miles. Effects of glucagon on free fatty acid metabolism in humans. J. Clin. Endocrinol. Metab. 72: 308-315, 1991.
22. Jensen, M. D., P. J. Rogers, M. G. Ellman, and J. M. Miles. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am. J. Physiol. 254 (Endocrinol. Metab. 17): E562-E565, 1988.
23. Kahn, C. R. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27, Suppl. 2: 1893-1902, 1978.
24. Lafontan, M., L. Dang-Tran, and M. Berlan. Alpha-adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: comparison with adrenaline responsiveness of different fat deposits. Eur. J. Clin. Invest. 9: 261-266, 1979.
25. Liggett, S. B., S. D. Shah, and P. E. Cryer. Human tissue adrenergic receptors are not predictive of responses to epinephrine in vivo. Am. J. Physiol. 256 (Endocrinol. Metab. 19): E600-E609, 1989.
26. Miles, J. M., M. G. Ellman, K. L. McClean, and M. D. Jensen. Validation of a new method for determination of free fatty acid turnover. Am. J. Physiol. 252 (Endocrinol. Metab. 15): E431-E438, 1987.
27. Miles, J. M., R. Glasscock, J. Aikens, J. E. Gerich, and M. W. Raymond. A microfluorometric method for the determination of free fatty acids in plasma. J. Lipid Res. 24: 96-99, 1983.
28. Miles, J. M., and M. D. Jensen. Does glucagon regulate adipose tissue lipolysis? J. Clin. Endocrinol. Metab. 77: 5-6, 1993.
29. Nakagawa, S., H. Nakayam, T. Sasaki, K. Yoshino, Y.-Y. Yu, K. Shinozaki, S. Aoki, and K. Mashimo. A simple method for the determination of serum free insulin levels in insulin treated patients. Diabetes 22: 590-600, 1973.
30. Shah, S. D., W. E. Clutter, and P. E. Cryer. External and internal standards in the single isotope derivative (radioenzymatic) assay of norepinephrine and epinephrine in normal humans and persons with diabetes mellitus or chronic renal failure. J. Lab. Clin. Med. 106: 624-629, 1985.
31. Steiner, K. E., H. Fuchs, P. E. Williams, R. W. Stevenson, A. D. Cherrington, and K. G. M. M. Alberti. Regulation of ketogenesisby epinephrine and norepinephrine in the overnight-fasted, conscious dog. Diabetes 34: 425-432, 1985.
32. Van Harken, D. R., C. W. Dixon, and M. Heimberg. Hepatic lipid metabolism in experimental diabetes. V. The effect of concentration of oleate on metabolism of triglycerides and on ketogenesis (Abstract). J. Biol. Chem. 244: 2278-2285, 1969.
33. Wahrenberg, H., P. Arner, U. Adamsson, P. E. Lins, A. Jublin-Dannfelt, and J. Östman. Increased lipolytic sensitivity to catecholamines in diabetic patients with severe autonomic neuropathy. J. Intern. Med. 227: 309-316, 1990.
34. Wahrenberg, H., F. Lönnquist, P. Engfeldt, and P. Arner. Abnormal action of catecholamines on lipolysis in adipocytes of type I diabetes patients treated with insulin. Diabetes 38: 524-533, 1989.
35. Weiss, M., U. Keller, and W. Stauffacher. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man. Diabetes 33: 738-744, 1984.